AstraZeneca (AstraZeneca) Marketable Securities : $180 Mil (As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is AstraZeneca Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. AstraZeneca's Marketable Securities for the quarter that ended in Mar. 2024 was $180 Mil.

AstraZeneca's annual Marketable Securities increased from Dec. 2021 ($69 Mil) to Dec. 2022 ($77 Mil) but then declined from Dec. 2022 ($77 Mil) to Dec. 2023 ($20 Mil).

AstraZeneca Marketable Securities Historical Data

The historical data trend for AstraZeneca's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Marketable Securities Chart

AstraZeneca Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

849.00

160.00

69.00

77.00

20.00

AstraZeneca Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															230.00	148.00	244.00	20.00	180.00

AstraZeneca Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

AstraZeneca (NAS:AZN) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

AstraZeneca Marketable Securities Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca (AstraZeneca) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (NAS:AZN) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

AZNCF:USA AZN:Sweden AZNN:Mexico AZNl:UK AZN:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany A1ZN34:Brazil

Address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA

Website

https://www.astrazeneca.com

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.